【摘 要】
：
目的 Acute graft-versus-host disease (aGVHD) is a major limitation of allogeneic hematopoietic stem cell transplantation (allo-HSCT).The mechanism of aGVHD has not been completely elucidated.
【机 构】
：
Peking University People's Hospital, Peking University Institute of Hematology 100044
【出 处】
：
中华医学会血液学分会第九次全国造血干细胞移植学术会议
论文部分内容阅读
目的 Acute graft-versus-host disease (aGVHD) is a major limitation of allogeneic hematopoietic stem cell transplantation (allo-HSCT).The mechanism of aGVHD has not been completely elucidated.
其他文献
目的 Despite a remarkable progress in lymphoma treatment over the past decades, chemotherapy resistance and disease relapse become the main obstacles to further improve the prognosis of the patients.Ind
目的 In the current, many studies investigating acute graft-versus-host disease (aGVHD) after hematopoietic stem cell transplantation (HSCT) have focused on seeking potential biomarkers to predict its o
目的 研究内皮祖细胞(EPC)对异基因移植后细胞因子释放的作用影响.方法 以C57BL/6小鼠为供鼠,BABL/C小鼠为受鼠并将其随机分为3组,即对照组:正常小鼠、单纯骨髓移植组;实验组:骨髓联合EPC移植组,于移植后2、4、6、8、10天利用流式细胞术,CBA法检测BABL/C小鼠血清中IL-6、IL-10、MCP1、IFN-γ、TNF-α、IL-12p70的水平.
目的 Tight regulation of the cell cycle in hematopoietic stem cells (HSCs) is essential for maintaining their lifelong self-renewal capacity.
目的 Human cytomegalovirus (HCMV) infection is a common complication of allo-hematopoietic stem cell transplantation (allo-HSCT), which is associated with high morbidity and mortality.
目的 FHL2, a member of the four and one half LIM domain protein family, is a critical transcriptionalmodulator.
目的 Prolonged isolated thrombocytopenia (PIT) represents a significant complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT), and is associated with an adverse patient progn
目的 观察G-CSF动员的半相合异基因外周造血干细胞输注联合化疗治疗恶性血液病的安全性.方法 17例恶性血液病患者在化疗结束24-48h内给予半相合异基因外周造血干细胞输注,共3疗程;12例急性髓系白血病患者,5例骨髓增生异常综合症患者;17例均为亲缘关系供者,其中12对供受者3个位点相合,5对为4个位点相合.
目的 Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for malignant hematological diseases, but prolonged isolated thrombocytopenia (PIT) following allo-HSCT seri
目的 The advantages of using cord blood (CB) over bone marrow (BM) and mobilized peripheral blood as source of hematopoietic stem cell transplantation (HSCT) include easy availability, tolerance to huma